Clinical Trials Browser

INDUSTRY × tenalisib × Other hematologic neoplasm × Clear all

NCT04204057 2024-08-13

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

21 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03711604 2024-05-08

Compassionate Use Study of Tenalisib (RP6530)

Phase 1/2 Completed

17 enrolled 9 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT02017613 2016-06-24

PI3K

Phase 1 Completed

DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous